Key result
Normalized blood pressure measurement with a double-cuff sphygmotonometer achieved 82% sensitivity and 90% specificity for identifying WHO-I stage hypertension, outperforming office MBP.
Why the study?
Does normalized blood pressure measurement with a double-cuff sphygmotonometer accurately estimate true basal blood pressure and improve identification of hypertension severity in unmedicated subjects?
Cross-Sectional (n=210)
Does normalized blood pressure measurement with a double-cuff sphygmotonometer accurately estimate true basal blood pressure and improve identification of hypertension severity in unmedicated subjects?
A novel double-cuff sphygmotonometer with a normalizing function accurately estimates basal blood pressure and improves the identification of hypertension severity compared to standard office measurements.
Answers are grounded in this paper and cite their sources.
Normalized double-cuff measurements may improve hypertension detection; hypothesis-generating and should not yet change practice.
BACKGROUND: In our previous studies of 24-h blood pressure measurement, basal blood pressure (minimum sleep-time blood pressure) showed the strongest correlation with hypertensive target-organ damage. We have currently devised a new accurate method of blood pressure measurement that entails recording casual blood pressure waves by means of a double-cuff sphygmotonometer, and attempted to normalize casual blood pressure to basal blood pressure. METHODS: The double-cuff sphygmotonometer records the arterial pressure wave, from which, using the formula (P0 = phi(-1)(i) x Pi), we attempted a normalization of casual blood pressure (Pi) to values close to those of the basal blood pressure (P0). True basal blood pressure was measured by an indirect ambulatory blood pressure monitoring device (TM2425, A&D Co. Ltd., Tokyo, Japan). The subjects were 54 normotensive volunteers and 156 out-patients with essential hypertension [63 with World Health Organization (WHO)-II stage and 93 with WHO-I stage, including 47 subjects with white-coat hypertension] not receiving medication. RESULTS: The coefficient of correlation (r) between normalized diastolic blood pressure (Pd0') and true diastolic basal blood pressure (Pd0) was 0.82 (mean difference = 1 +/- 9.8 mmHg), that between normalized systolic blood pressure (Ps0') and true systolic basal blood pressure (Ps0) being 0.78 (1 +/- 13 mmHg) in 210 subjects. When an office mean blood pressure (MBP) of 116 mmHg was taken as the standard for identifying the WHO-I group, the sensitivity was 70% (65/93) and the specificity 67% (42/63), but when an MBP0 [MBP0' = (Ps0'-Pd0')/3 + Pd0'] of 89 mmHg was the standard, the sensitivity was 82% (76/93) and the specificity 90% (57/63), both significantly higher than the corresponding values for office MBP (P < 0.05). CONCLUSION: We devised a new double-cuff sphygmotonometer and normalizing function (phi(-1)) and, using these methods, calculated the normalized blood pressure in hypertensive out-patients, which may make it possible to identify degrees of severity of hypertension in terms of WHO stages.
No takes yet. Share an insight, caveat, or question.
Tochikubo et al. (2001) conducted a cross-sectional in Essential hypertension (n=210). Normalized blood pressure measurement with a double-cuff sphygmotonometer vs. Office mean blood pressure was evaluated on Sensitivity for identifying WHO-I stage hypertension (p=< 0.05). Normalized blood pressure measurement with a double-cuff sphygmotonometer achieved 82% sensitivity and 90% specificity for identifying WHO-I stage hypertension, outperforming office MBP.
Synapse has enriched 10 related papers. Consider them for comparative context: